Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1992-3-11
|
pubmed:abstractText |
Immunoassays were developed to detect antibodies against oligopeptides deduced from the putative core gene of hepatitis C virus, and their performances were compared with that of the commercial immunoassay for antibodies against the product of nonstructural regions of hepatitis C virus (anti-C100-3). A 19-mer oligopeptide (CP10) and a 36-mer oligopeptide (CP9) were chemically synthesized, which represented hydrophilic regions of the product of the hepatitis C virus core gene. They were used to capture corresponding antibodies, anti-CP10 and anti-CP9, by enzyme-linked immunosorbent assay in sera from patients with acute or chronic non-A, non-B liver disease and in blood donations. At the onset of acute non-A, non-B hepatitis, anti-CP10 was detected in 15 of 20 patients (75%), and anti-CP9 was detected in 14 patients (70%). This was more frequent than anti-C100-3, which was found in only 9 patients (45%). In 186 patients with chronic non-A, non-B liver disease, anti-CP9, anti-CP10 or both were detected in 170 patients (91%). This was more frequent than anti-C100-3, which was found in 138 patients (74%). Blood with anti-CP10 as the single serological marker for hepatitis C virus infection transmitted non-A, non-B hepatitis by needlestick exposure. In sera from 558 apparently healthy blood donors, anti-CP10 was detected in 55 donors (9.9%), anti-CP9 was detected in 26 donors (4.7%) and anti-C100-3 was detected in 7 donors (1.3%).(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0270-9139
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
180-6
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1370946-Amino Acid Sequence,
pubmed-meshheading:1370946-Blood Donors,
pubmed-meshheading:1370946-Cross Infection,
pubmed-meshheading:1370946-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:1370946-Genes, Viral,
pubmed-meshheading:1370946-Health Personnel,
pubmed-meshheading:1370946-Hepatitis Antibodies,
pubmed-meshheading:1370946-Hepatitis C,
pubmed-meshheading:1370946-Hepatitis C Antibodies,
pubmed-meshheading:1370946-Humans,
pubmed-meshheading:1370946-Molecular Sequence Data,
pubmed-meshheading:1370946-Oligopeptides,
pubmed-meshheading:1370946-Renal Dialysis,
pubmed-meshheading:1370946-Viral Core Proteins
|
pubmed:year |
1992
|
pubmed:articleTitle |
Antibodies against synthetic oligopeptides deduced from the putative core gene for the diagnosis of hepatitis virus infection.
|
pubmed:affiliation |
Immunology Division, Jichi Medical School, Tochigi-Ken, Japan.
|
pubmed:publicationType |
Journal Article
|